NYSE:TRLVPharmaceuticals
Trulieve Cannabis (TRLV) Could Be 51% Undervalued After Georgia Medical Cannabis Expansion
Trulieve Cannabis (TRLV) stock is in focus after Georgia expanded its medical cannabis program under Senate Bill 220, allowing flower and vaporization products and broadening patient access across the state.
See our latest analysis for Trulieve Cannabis.
Trulieve Cannabis shares have been volatile around the Georgia news. The latest share price is $9.54 after a 1 day share price return that declined 2.95%. However, a 90 day share price return of 57.95% and a 1 year total shareholder return of...